-
![[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors](/abs-image/US/2015/01/27/US08940761B2/abs.jpg.150x150.jpg)
公开(公告)号：US08940761B2
公开(公告)日：2015-01-27
申请号：US14361356
申请日：2012-12-19
Applicant: Leo Pharma A/S
Inventor： Simon Feldbæk Nielsen , Jens Christian Højland Larsen
IPC: A61K31/437 , C07D471/04
CPC classification number: C07D471/04 , A61K31/437
Abstract: The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
-
![[1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS](/abs-image/US/2014/11/06/US20140329853A1/abs.jpg.150x150.jpg)
2.发明申请[1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS 有权[1,2,4]三唑并嘧啶及其作为磷酸二酯酶抑制剂的用途公开(公告)号：US20140329853A1
公开(公告)日：2014-11-06
申请号：US14361356
申请日：2012-12-19
Applicant: LEO PHARMA A/S
Inventor： Simon Feldbæk Nielsen , Jens Christian Højland Larsen
IPC: C07D471/04 , A61K31/437
CPC classification number: C07D471/04 , A61K31/437
Abstract: The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Abstract translation: 本发明涉及具有磷酸二酯酶抑制活性的新型[1,2,4]三唑并吡啶化合物，以及它们在治疗炎性疾病和病症中作为治疗剂的用途。
-
Search Results
2
records
(took 0.026 seconds)
